Get started
Author

Stephanie C. Liu

OpenAlex ID: A5021178352
Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA -Mutant Breast Cancer
2016 · Wei Yang, Sarah R. Hosford, et al. · Clinical Cancer Research · 33
A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition
2019 · Kevin Shee, Jason D. Wells, et al. · Clinical Cancer Research · 2
Supplementary data from Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA-Mutant Breast Cancer
2023 · Wei Yang, Sarah R. Hosford, et al.
Supplementary Data from A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition
2023 · Kevin Shee, Jason D. Wells, et al.
Supplementary Tables from A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition
2023 · Kevin Shee, Jason D. Wells, et al.
Data from Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA-Mutant Breast Cancer
2023 · Wei Yang, Sarah R. Hosford, et al.
Data from A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition
2023 · Kevin Shee, Jason D. Wells, et al.
Data from A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition
2023 · Kevin Shee, Jason D. Wells, et al.
Data from Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA-Mutant Breast Cancer
2023 · Wei Yang, Sarah R. Hosford, et al.
Supplementary data from Strategically Timing Inhibition of Phosphatidylinositol 3-Kinase to Maximize Therapeutic Index in Estrogen Receptor Alpha–Positive, PIK3CA-Mutant Breast Cancer
2023 · Wei Yang, Sarah R. Hosford, et al.
Supplementary Tables from A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition
2023 · Kevin Shee, Jason D. Wells, et al.
Supplementary Data from A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition
2023 · Kevin Shee, Jason D. Wells, et al.
Works count: 12
Citation count: 35
H-index: 2
I10-index: 1
Year
Topic
Type